Overview
Hironori Ishiguchi practices in Ube, Japan. Ishiguchi is highly rated in 8 conditions, according to our data. Their top areas of expertise are Atrial Fibrillation, Cardiac Tamponade, Familial Progressive Cardiac Conduction Defect, Cardiac Ablation, and Embolectomy.
Their clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Coronary SyndromeIshiguchi isAdvanced. Learn about Acute Coronary Syndrome.
- ArrhythmiasIshiguchi isAdvanced. Learn about Arrhythmias.
- Atrial FibrillationIshiguchi isAdvanced. Learn about Atrial Fibrillation.
- Cardiac AblationIshiguchi isAdvanced. Learn about Cardiac Ablation.
- Cardiac TamponadeIshiguchi isAdvanced. Learn about Cardiac Tamponade.
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Experienced
- AnginaIshiguchi isExperienced. Learn about Angina.
- CardiomyopathyIshiguchi isExperienced. Learn about Cardiomyopathy.
- Cardiomyopathy Due to AnthracyclinesIshiguchi isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- DextrocardiaIshiguchi isExperienced. Learn about Dextrocardia.
- Dextrocardia with Situs InversusIshiguchi isExperienced. Learn about Dextrocardia with Situs Inversus.
- Doxorubicin-Induced CardiomyopathyIshiguchi isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.